Lux Capital is an investment firm investing in counter-conventional, early-stage science, and tech ventures.
Lux Capital Management manages of $4 billion in assets focused on founding, seed, early-stage, and growth investments in the physical, material and life sciences. Lux takes an active role in helping entrepreneurs build successful businesses in high growth sectors. Its investment team has built over 20 companies from scratch. Lux's investment strategy ensures our portfolio companies are better connected, have a deeper insight, and command industry leadership faster than their competitors.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Dec 21, 2022
Enveda Biosciences
|
Series B | $55M | Biotechnology | — |
Dec 5, 2022
Runway
|
Series C | $50M | Artificial Intelligence | — |
Dec 2, 2022
Anduril Industries
|
Series E | $1.48B | Aerospace | — |
Nov 29, 2022
Cajal Neuroscience
|
Series A | $96M | Biotechnology | Yes |
Oct 11, 2022
Stairwell
|
Series B | $45M | Cyber Security | — |